{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T17:13:23Z","timestamp":1792516403591,"version":"4.5.0"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,2]]},"DOI":"10.1097\/01.pas.0000149689.75462.ff","type":"journal-article","created":{"date-parts":[[2005,1,11]],"date-time":"2005-01-11T04:01:09Z","timestamp":1105416069000},"page":"196-203","source":"Crossref","is-referenced-by-count":43,"title":["TRAF1 Expression and c-Rel Activation Are Useful Adjuncts in Distinguishing Classical Hodgkin Lymphoma From a Subset of Morphologically or Immunophenotypically Similar Lymphomas"],"prefix":"10.1097","volume":"29","author":[{"given":"Scott J","family":"Rodig","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerry J","family":"Savage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vuong","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geraldine S","family":"Pinkus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret A","family":"Shipp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon C","family":"Aster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffery L","family":"Kutok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-6-20210130","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1006\/excr.2002.5515","article-title":"Stable inhibition of NF-kappa B in salivary gland cells does not enhance sensitivity to TNF-alpha-induced apoptosis due to upregulation of TRAF1 expression.","volume":"276","author":"Aota","year":"2002","journal-title":"Exp Cell Res"},{"key":"R2-6-20210130","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1038\/sj.onc.1202568","article-title":"Modulation of life and death by the TNF receptor superfamily.","volume":"17","author":"Baker","year":"1998","journal-title":"Oncogene"},{"key":"R3-6-20210130","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1006\/bbrc.1997.6509","article-title":"Binding sites of cytoplasmic effectors TRAF1, 2, and 3 on CD30 and other members of the TNF receptor superfamily.","volume":"233","author":"Boucher","year":"1997","journal-title":"Biochem Biophys Res Commun"},{"key":"R4-6-20210130","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1309\/YCH8DWUFFQBKGPVB","article-title":"The B-cell transcription factors BSAP, Oct-2, and BOB.1 and the pan-B-cell markers CD20, CD22, and CD79a are useful in the differential diagnosis of classic Hodgkin lymphoma.","volume":"120","author":"Browne","year":"2003","journal-title":"Am J Clin Pathol"},{"key":"R5-6-20210130","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S1359-6101(03)00021-2","article-title":"The signaling adaptors and pathways activated by TNF superfamily.","volume":"14","author":"Dempsey","year":"2003","journal-title":"Cytokine Growth Factor Rev"},{"key":"R6-6-20210130","first-page":"508","article-title":"An evaluation of the utility of anti-granulocyte and anti-leukocyte monoclonal antibodies in the diagnosis of Hodgkins disease.","volume":"123","author":"Dorfman","year":"1986","journal-title":"Am J Pathol"},{"key":"R7-6-20210130","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1128\/JVI.78.4.1800-1816.2004","article-title":"Nuclear factor kappa B-dependent activation of the antiapoptotic bfl-1 gene by the Epstein-Barr virus latent membrane protein 1 and activated CD40 receptor.","volume":"78","author":"D'Souza","year":"2004","journal-title":"J Virol"},{"key":"R8-6-20210130","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1128\/MCB.17.3.1535","article-title":"Induction of nuclear factor kappaB by the CD30 receptor is mediated by TRAF1 and TRAF2.","volume":"17","author":"Duckett","year":"1997","journal-title":"Mol Cell Biol"},{"key":"R9-6-20210130","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1182\/blood.V93.2.617","article-title":"Tumor necrosis factor receptor-associated factor 1 is overexpressed in Reed-Sternberg cells of Hodgkins disease and Epstein-Barr virus-transformed lymphoid cells.","volume":"93","author":"Durkop","year":"1999","journal-title":"Blood"},{"key":"R10-6-20210130","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/path.1351","article-title":"Differential expression and function of A20 and TRAF1 in Hodgkin lymphoma and ALCL and their induction by CD30 stimulation.","volume":"200","author":"Durkop","year":"2003","journal-title":"J Pathol"},{"key":"R11-6-20210130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/blood.V85.1.1.bloodjournal8511","article-title":"CD30 (Ki-1) molecule: a new cytokine receptor of the tumor necrosis factor receptor superfamily as a tool for diagnosis and immunotherapy.","volume":"85","author":"Falini","year":"1995","journal-title":"Blood"},{"key":"R12-6-20210130","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1136\/jcp.40.11.1298","article-title":"Value of CD15 immunostaining in diagnosing Hodgkins disease: a review of published literature.","volume":"40","author":"Hall","year":"1987","journal-title":"J Clin Pathol"},{"key":"R13-6-20210130","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1182\/blood.V97.9.2798","article-title":"Constitutive NF-kappaB maintains high expression of a characteristic gene network, including CD40, CD86, and a set of antiapoptotic genes in Hodgkin\/Reed-Sternberg cells.","volume":"97","author":"Hinz","year":"2001","journal-title":"Blood"},{"key":"R14-6-20210130","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/intimm\/10.2.203","article-title":"A novel domain in the CD30 cytoplasmic tail mediates NFkappaB activation.","volume":"10","author":"Horie","year":"1998","journal-title":"Int Immunol"},{"key":"R15-6-20210130","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/BF02982601","article-title":"Hodgkins lymphoma and CD30 signal transduction.","volume":"77","author":"Horie","year":"2003","journal-title":"Int J Hematol"},{"key":"R16-6-20210130","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/modpathol.3880306","article-title":"Characterization of NF-kappaB expression in Hodgkins disease: inhibition of constitutively expressed NF-kappaB results in spontaneous caspase-independent apoptosis in Hodgkin and Reed-Sternberg cells.","volume":"14","author":"Izban","year":"2001","journal-title":"Mod Pathol"},{"key":"R17-6-20210130","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/modpathol.3880243","article-title":"Expression of the tumor necrosis factor receptor-associated factors (TRAFs) 1 and 2 is a characteristic feature of Hodgkin and Reed-Sternberg cells.","volume":"13","author":"Izban","year":"2000","journal-title":"Mod Pathol"},{"key":"R19-6-20210130","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1038\/sj.onc.1202351","article-title":"Molecular mechanisms of constitutive NF-kappaB\/Rel activation in Hodgkin\/Reed-Sternberg cells.","volume":"18","author":"Krappmann","year":"1999","journal-title":"Oncogene"},{"key":"R20-6-20210130","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1053\/hupa.2001.29679","article-title":"Inflammatory pseudotumor of lymph node and spleen: an entity biologically distinct from inflammatory myofibroblastic tumor.","volume":"32","author":"Kutok","year":"2001","journal-title":"Hum Pathol"},{"key":"R21-6-20210130","first-page":"211","article-title":"Hodgkins disease, lymphocyte predominance type, nodular-further evidence for a B cell derivation. L H variants of Reed-Sternberg cells express L26, a pan B cell marker.","volume":"133","author":"Pinkus","year":"1988","journal-title":"Am J Pathol"},{"key":"R22-6-20210130","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/1097-0142(19910715)68:2<362::AID-CNCR2820680226>3.0.CO;2-C","article-title":"Ki- 1-positive large cell lymphomas, a heterogenous group of neoplasms: morphologic, immunophenotypic, genotypic, and clinical features of 24 cases.","volume":"68","author":"Penny","year":"1991","journal-title":"Cancer"},{"key":"R23-6-20210130","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1309\/GQ2RLNDWLB9WY6UU","article-title":"Clusterin, a marker for anaplastic large cell lymphoma immunohistochemical profile in hematopoietic and nonhematopoietic malignant neoplasms.","volume":"121","author":"Nascimento","year":"2004","journal-title":"Am J Clin Pathol"},{"key":"R24-6-20210130","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1073\/pnas.2237183100","article-title":"Epstein-Barr virus latent infection membrane protein 1 TRAF-binding site induces NIK\/IKK alpha-dependent noncanonical NF-kappaB activation.","volume":"101","author":"Luftig","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"R25-6-20210130","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1002\/1097-0142(19881215)62:12<2475::AID-CNCR2820621204>3.0.CO;2-4","article-title":"Utility of combining antigranulocyte with antileukocyte antibodies in differentiating Hodgkins disease from non-Hodgkins lymphoma.","volume":"62","author":"Medeiros","year":"1988","journal-title":"Cancer"},{"key":"R26-6-20210130","doi-asserted-by":"crossref","first-page":"4307","DOI":"10.1182\/blood.V96.13.4307","article-title":"Differential effects of CD30 activation in ALCL and Hodgkin disease cells.","volume":"96","author":"Mir","year":"2000","journal-title":"Blood"},{"key":"R27-6-20210130","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1136\/jcp.40.12.1405","article-title":"Monoclonal antibody L26: an antibody that is reactive with normal and neoplastic B lymphocytes in routinely fixed and paraffin wax embedded tissues.","volume":"40","author":"Norton","year":"1987","journal-title":"J Clin Pathol"},{"key":"R28-6-20210130","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/ajcp\/104.4.413","article-title":"Correlation between presence of clonal rearrangements of immunoglobulin heavy chain genes and B-cell antigen expression in Hodgkins disease.","volume":"104","author":"Orazi","year":"1995","journal-title":"Am J Clin Pathol"},{"key":"R29-6-20210130","first-page":"543","article-title":"Fascin, a sensitive new marker for Reed-Sternberg cells of Hodgkins disease: evidence for a dendritic or B cell derivation?","volume":"150","author":"Pinkus","year":"1997","journal-title":"Am J Pathol"},{"key":"R30-6-20210130","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1084\/jem.20031074","article-title":"Molecular diagnosis of primary mediastinal B-cell lymphoma identifies a clinically favorable subgroup of diffuse large B-cell lymphoma related to Hodgkin lymphoma.","volume":"198","author":"Rosenwald","year":"2003","journal-title":"J Exp Med"},{"key":"R31-6-20210130","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1182\/blood-2003-06-1841","article-title":"The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma.","volume":"102","author":"Savage","year":"2003","journal-title":"Blood"},{"key":"R32-6-20210130","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1080\/10428190290033288","article-title":"Pleiotropic signal transduction mediated by human CD30: a member of the tumor necrosis factor receptor (TNFR) family.","volume":"43","author":"Schneider","year":"2002","journal-title":"Leuk Lymphoma"},{"key":"R33-6-20210130","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/00000478-198604000-00001","article-title":"Leu-M1 antigen in human neoplasms: an immunohistologic study of 400 cases.","volume":"10","author":"Sheibani","year":"1986","journal-title":"Am J Surg Pathol"},{"key":"R34-6-20210130","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1136\/mp.56.3.156","article-title":"Epstein-Barr virus encoded latent membrane protein 1 (LMP1) and TNF receptor associated factors (TRAF): colocalisation of LMP1 and TRAF1 in primary EBV infection and in EBV associated Hodgkin lymphoma.","volume":"56","author":"Siegler","year":"2003","journal-title":"Mol Pathol"},{"key":"R35-6-20210130","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/ajcp\/85.3.283","article-title":"The spectrum of Leu-M1 staining in lymphoid and hematopoietic proliferations.","volume":"85","author":"Swerdlow","year":"1986","journal-title":"Am J Clin Pathol"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/01.pas.0000149689.75462.ff","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T13:42:01Z","timestamp":1785850921000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000478-200502000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005]]}},"URL":"https:\/\/doi.org\/10.1097\/01.pas.0000149689.75462.ff","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2005,2]]}}}